Compounds > canertinib
Page last updated: 2024-09-04

canertinib and Non-alcoholic Fatty Liver Disease

canertinib has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banerjee, S; Bhushan, B; Bowen, WC; Koral, K; Locker, J; Mars, WM; Michalopoulos, GK; Orr, A; Paranjpe, S; Stoops, JW1

Other Studies

1 other study(ies) available for canertinib and Non-alcoholic Fatty Liver Disease

ArticleYear
Pharmacologic Inhibition of Epidermal Growth Factor Receptor Suppresses Nonalcoholic Fatty Liver Disease in a Murine Fast-Food Diet Model.
    Hepatology (Baltimore, Md.), 2019, Volume: 70, Issue:5

    Topics: Animals; Disease Models, Animal; ErbB Receptors; Fast Foods; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Morpholines; Non-alcoholic Fatty Liver Disease

2019